{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:44:17Z","timestamp":1781228657177,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.yexmp.2013.10.014","type":"journal-article","created":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T04:01:04Z","timestamp":1383624064000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis"],"prefix":"10.1016","volume":"96","author":[{"given":"Stavroula","family":"Samara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3890-0832","authenticated-orcid":false,"given":"Zoe","family":"Dailiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Chassanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Koromila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loukia","family":"Papatheodorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6594-3649","authenticated-orcid":false,"given":"Konstantinos N.","family":"Malizos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagoula","family":"Kollia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2013.10.014_bb0005","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s001980070028","article-title":"Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis","volume":"11","author":"Aubin","year":"2000","journal-title":"Osteoporos. Int."},{"issue":"10","key":"10.1016\/j.yexmp.2013.10.014_bb0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jcp.54.10.778","article-title":"High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma","volume":"54","author":"Baelde","year":"2001","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.yexmp.2013.10.014_bb0015","first-page":"168","article-title":"Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults","volume":"425","author":"Bj\u00f6rkman","year":"2004","journal-title":"Arch. Orthop. Trauma Surg."},{"issue":"2","key":"10.1016\/j.yexmp.2013.10.014_bb0020","first-page":"631","article-title":"Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women","volume":"86","author":"Browner","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.yexmp.2013.10.014_bb0025","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.yexmp.2013.10.014_bb0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/er.2002-0023","article-title":"Bone morphogenetic protein, their antagonists, and the skeleton","volume":"24","author":"Canalis","year":"2003","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.yexmp.2013.10.014_bb0035","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.transproceed.2005.12.062","article-title":"Association of corticosteroids and factor V, prothrombin, and MTHFR gene mutations with avascular osteonecrosis in renal allograft recipients","volume":"38","author":"Celik","year":"2006","journal-title":"Transplant. Proc."},{"issue":"4","key":"10.1016\/j.yexmp.2013.10.014_bb0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08977190412331279890","article-title":"Bone morphogenetic proteins","volume":"22","author":"Chen","year":"2004","journal-title":"Growth Factors"},{"issue":"8","key":"10.1016\/j.yexmp.2013.10.014_bb0045","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2106\/00004623-200308000-00017","article-title":"Osteogenic activity of fourteen types of human bone morhpogenetic proteins (BMPs)","volume":"85A","author":"Cheng","year":"2003","journal-title":"J. Bone. Joint Surg. Am."},{"issue":"12","key":"10.1016\/j.yexmp.2013.10.014_bb0050","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1359\/jbmr.2003.18.12.2095","article-title":"Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype","volume":"18","author":"Chong","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"18","key":"10.1016\/j.yexmp.2013.10.014_bb0055","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/hmg\/11.18.2119","article-title":"A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype","volume":"11","author":"Cundy","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.yexmp.2013.10.014_bb0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.2249","article-title":"Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture","volume":"44","author":"Estrada","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexmp.2013.10.014_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003086-200105000-00004","article-title":"Hypofibrinolysis, thrombophilia","volume":"386","author":"Glueck","year":"2001","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"1","key":"10.1016\/j.yexmp.2013.10.014_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00256-007-0395-2","article-title":"Genetic association studies in osteonecrosis of the femoral head","volume":"37","author":"Hadjigeorgiou","year":"2008","journal-title":"Skelet. Radiol."},{"issue":"2","key":"10.1016\/j.yexmp.2013.10.014_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.RES.00000175571.53833.6c","article-title":"Bone morphogenetic proteins in vascular calcification","volume":"97","author":"Hruska","year":"2005","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yexmp.2013.10.014_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/71667","article-title":"Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis","volume":"24","author":"Hughes","year":"2000","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.yexmp.2013.10.014_bb0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00774-003-0461-3","article-title":"Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios","volume":"22","author":"Jorgensen","year":"2004","journal-title":"J. Bone Miner. Metab."},{"issue":"2","key":"10.1016\/j.yexmp.2013.10.014_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1874467211205020153","article-title":"The role of BMPs in bone anabolism and their potential targets SOST and DKK1","volume":"5","author":"Kamiya","year":"2012","journal-title":"Curr. Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.yexmp.2013.10.014_bb0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/er.2007-0014","article-title":"Receptor activator of nuclear factor \u03baB ligand and osteoprotegerin regulation of bone remodeling in health and disease","volume":"29","author":"Kearns","year":"2008","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.yexmp.2013.10.014_bb0100","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.coph.2005.06.005","article-title":"Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength","volume":"5","author":"Kostenuik","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.yexmp.2013.10.014_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.yexmp.2013.10.014_bb9000","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1196\/annals.1443.016","article-title":"RANK\/RANKL: regulators of immune responses and bone physiology. Ann. N.Y","volume":"1143","author":"Leibbrant","year":"2008","journal-title":"Acad. Sci."},{"issue":"4","key":"10.1016\/j.yexmp.2013.10.014_bb0110","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.yexmp.2013.10.014_bb0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bdj.4807835","article-title":"Bone remodelling","volume":"172","author":"Meghji","year":"1992","journal-title":"Br. Dent. J."},{"issue":"355 Suppl.","key":"10.1016\/j.yexmp.2013.10.014_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00003086-199810001-00032","article-title":"Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors","author":"Mont","year":"1998","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"11","key":"10.1016\/j.yexmp.2013.10.014_bb0125","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1210\/jc.2005-0794","article-title":"Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment","volume":"90","author":"Rogers","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.yexmp.2013.10.014_bb0130","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1007\/s11033-013-2538-y","article-title":"Bone morphogenetic proteins (BMPs) expression in the femoral heads of patients with avascular necrosis","volume":"40","author":"Samara","year":"2013","journal-title":"Mol. Biol. Rep."},{"issue":"9","key":"10.1016\/j.yexmp.2013.10.014_bb0135","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jama.291.9.1108","article-title":"Soluble RANKL and risk of nontraumatic fracture","volume":"291","author":"Schett","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.yexmp.2013.10.014_bb0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.yexmp.2013.10.014_bb0145","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00003086-200105000-00016","article-title":"Treatment of avascular necrosis of the femoral head with vascularized fibular transplant","volume":"386","author":"Soucacos","year":"2001","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.yexmp.2013.10.014_bb0150","first-page":"345","article-title":"Receptor activator of nuclear factor-\u03baB ligand and osteoprotegerin: maintaining the balance to prevent bone loss","volume":"5","author":"Trouvin","year":"2010","journal-title":"Clin. Interv. Aging"},{"issue":"1","key":"10.1016\/j.yexmp.2013.10.014_bb0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1385\/MB:23:1:37","article-title":"A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone","volume":"23","author":"Tuli","year":"2003","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.yexmp.2013.10.014_bb0160","series-title":"Osteonecrosis: etiology, diagnosis and treatment","author":"Urbaniak","year":"1997"},{"issue":"1","key":"10.1016\/j.yexmp.2013.10.014_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL\u2013RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.yexmp.2013.10.014_bb0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1359\/jbmr.2002.17.1.26","article-title":"Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis","volume":"17","author":"Whyte","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.yexmp.2013.10.014_bb0170","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1359\/jbmr.2000.15.12.2330","article-title":"Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease","volume":"15","author":"Whyte","year":"2000","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.yexmp.2013.10.014_bb0180","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2362.2000.00621.x","article-title":"Potential aetiological factors concerning the development of osteonecrosis of the femoral head","volume":"30","author":"Zalavras","year":"2000","journal-title":"Eur. J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.yexmp.2013.10.014_bb0185","first-page":"111","article-title":"The 677C\u2192T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head","volume":"87","author":"Zalavras","year":"2002","journal-title":"Hematol."},{"key":"10.1016\/j.yexmp.2013.10.014_bb0190","first-page":"19","article-title":"The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues","volume":"1","author":"Zupan","year":"2012","journal-title":"J. Biomed. Sci."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480013001317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480013001317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T21:54:36Z","timestamp":1539208476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480013001317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0014480013001317"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2013.10.014","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2013.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}